Skip to main content
. 2021 Sep 30;53(10):1434–1442. doi: 10.1038/s41588-021-00930-y

Extended Data Fig. 1. Mutational signatures and structural variants in normal tissue from an individual exposed to oxaliplatin chemotherapy.

Extended Data Fig. 1

Mutational signatures identified in normal intestinal crypts from individual PD44592 who had previously undergone treatment with oxaliplatin. Distinctive SBS and DBS signatures were observed that have previously been associated with oxaliplatin treatment in cancer samples. Unexpectedly high numbers of structural variants were also observed in the normal intestinal crypts from this individual and may be due to chemotherapy exposure. (a) Phylogenetic tree from individual PD44592 with structural variants (SVs) mapped to branches. Shapes correspond to SV type; translocation (circle), inversion (hexagon), large duplication (square) and deletion (triangle). Ordering of SVs and positioning along branches is arbitrary (b) SBS signature SBS35-like displayed above the Pan-Cancer Analysis of Whole Genomes (PCAWG) reference signature SBS35 (PCAWG)9 and E-SBS2048 (c) Doublet Base Substitution (DBS) signature displayed above PCAWG reference signature DBS5 and E-DBS5 from Pich et al 201948. (d-e) Cosine similarity matrices for SBS and DBS signatures.